SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Bruze Magnus) "

Sökning: WFRF:(Bruze Magnus)

  • Resultat 31-40 av 401
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  •  
32.
  •  
33.
  •  
34.
  • Anveden, I, et al. (författare)
  • Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel
  • 2004
  • Ingår i: Contact Dermatitis. - : Wiley. - 0105-1873 .- 1600-0536. ; 50:5, s. 298-303
  • Tidskriftsartikel (refereegranskat)abstract
    • A multicentre, randomized, double-blind, crossover study was designed to investigate the effects of prednisone on allergic and irritant patch test reactions. 24 subjects with known allergy to nickel were recruited and patch tested with a nickel sulfate dilution series in aqueous solution, 5% nickel sulfate in petrolatum and 2 dilution series of the irritants nonanoic acid and sodium lauryl sulfate. The subjects were tested x2, both during treatment with prednisone 20 mg oral daily and during placebo treatment. The total number of positive nickel patch test reactions decreased significantly in patients during prednisone treatment. The threshold concentration to elicit a patch test reaction increased and the overall degree of reactivity to nickel sulfate shifted towards weaker reactions. The effect of prednisone treatment on the response to irritants was divergent with both increased and decreased numbers of reactions, although there were no statistically significant differences compared with placebo. It is concluded that oral treatment with prednisone suppresses patch test reactivity to nickel, but not to the irritants tested.
  •  
35.
  • Api, Anne Marie, et al. (författare)
  • Quantitative Risk Assessment of Contact Sensitization: Clinical Data to Assess Utility of the Model
  • 2010
  • Ingår i: Dermatitis. - : Mary Ann Liebert Inc. - 1710-3568. ; 21:4, s. 207-213
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Contact hypersensitivity quantitative risk assessment (QRA) for fragrance ingredients is being used to establish new international standards for all fragrance ingredients that are potential skin sensitizers. Objective: The objective was to evaluate the retrospective clinical data on three fragrance ingredients in order to provide a practical assessment of the predictive value of the QRA approach. It is important to have data to assess that the methodology provides a robust approach for primary prevention of contact sensitization induction for fragrance ingredients identified as potential sensitizers. Methods: This article reviews clinical data for three fragrance ingredients cinnamic aldehyde, citral, and isoeugenol to assess the utility of the QRA approach for fragrance ingredients. Results: This assessment suggests that had the QRA approach been available at the time standards were established for these fragrance ingredients, the clinical response might have been noticeably improved. Prospectively, with the establishment of QRA-derived standards, there should be a continued downward trend in patch test-positive rates for cinnamic aldehyde, citral, and isoeugenol over time. Conclusion: While it is recognized that the availability of retrospective data is limited, a longitudinal review of these data gives confidence that the QRA approach should be an effective tool for primary prevention. This study also highlights the importance of continued active monitoring of clinical patch-test data for fragrance ingredients.
  •  
36.
  •  
37.
  •  
38.
  • Balato, Anna, et al. (författare)
  • European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions
  • 2020
  • Ingår i: Journal of the European Academy of Dermatology and Venereology. - : Wiley. - 0926-9959 .- 1468-3083. ; 34:8, s. 353-354
  • Tidskriftsartikel (refereegranskat)abstract
    • Among the basic protective measures against COVID-19, the need to wash hands frequently and in a prolonged way using soap, and to regularly use alcohol-based hand sanitizers is well established for the whole population. Healthcare workers in general, and particularly those involved in the direct care of COVID-19 patients, have to wear personal protective equipment (PPE) daily for many hours and also accomplish general preventive measurements outside their work. Cutaneous adverse reactions can develop that need to be prevented, identified and therapeutically managed. According to the data reported by Lin et al 1, based in the experience from healthcare workers in Wuhan, adverse skin reactions were reported in 74% of responders (n=376) to a general survey. The most commonly reported types of eruptions were skin dryness or desquamation (68.6%), papules or erythema (60.4%) and maceration (52,9%).
  •  
39.
  • Belsito, D., et al. (författare)
  • A safety assessment of branched chain saturated alcohols when used as fragrance ingredients
  • 2010
  • Ingår i: Food and Chemical Toxicology. - : Elsevier BV. - 0278-6915. ; 48, s. 1-46
  • Forskningsöversikt (refereegranskat)abstract
    • The Branched Chain Saturated Alcohol (BCSA) group of fragrance ingredients was evaluated for safety. In humans, no evidence of skin irritation was found at concentrations of 2-10%. Undiluted, 11 materials evaluated caused moderate to severe eye irritation. As current end product use levels are between 0.001% and 1.7%, eye irritation is not a concern. The materials have no or low sensitizing potential. For individuals who are already sensitized, an elicitation reaction is possible. Due to lack of UVA/UVB light-absorbing structures, and review of phototoxic/photoallergy data, the BCSA are not expected to elicit phototoxicity or photoallergy. The 15 materials tested have a low order of acute toxicity. Following repeated application, seven BCSA tested were of low systemic toxicity. Studies performed on eight BCSA and three metabolites show no in vivo or in vitro genotoxicity. A valid carcinogenicity study showed that 2-ethyl-1-hexanol is a weak inducer of liver tumors in female mice, however, the relevance of this effect and mode of action to humans is still a matter of debate. The Panel is of the opinion that there are no safety concerns regarding BCSA under the present levels of use and exposure. (C) 2010 Elsevier Ltd. All rights reserved.
  •  
40.
  • Belsito, D., et al. (författare)
  • A toxicologic and dermatologic assessment of cinnamyl phenylpropyl materials when used as fragrance ingredients
  • 2011
  • Ingår i: Food and Chemical Toxicology. - : Elsevier BV. - 0278-6915. ; 49:Suppl. 2, s. 256-267
  • Forskningsöversikt (refereegranskat)abstract
    • The cinnamyl phenylpropyl fragrance ingredients are a diverse group of chemical structures that have similar metabolic and toxicity profiles. A toxicological and dermatological review of these fragrance ingredients is presented. The common characteristic structural element of cinnamyl phenylpropyl materials is an aryl substituted primary alcohol/aldehyde/ester. For high end users, calculated maximum dermal exposures vary from 0.14% to 0.72%; systemic exposures vary from 0.0002 to 0.0280 mg/kg/day. Human dermatological studies show that these materials are not generally irritants or sensitizers at lower exposures from consumer products. Reactions (0.9%) in fragrance sensitive patients were observed with 3-phenyl-1-propanol at 5% in petrolatum. The cinnamyl phenylpropyl materials had low acute toxicity and no significant toxicity in repeat dose oral or dermal toxicity studies. No mutagenic or genotoxic activity in bacteria and mammalian cell line assays was observed. The cinnamyl phenylpropyl alcohol materials participate in the same beta oxidation pathways as their parent cinnamic acid derivatives, including common routes of absorption, distribution, and metabolic detoxification, and exhibit similar toxicological endpoints. Based on the review of available data, it is concluded that these materials would not present a safety concern at current levels of use as fragrance ingredients. (C) 2011 Elsevier Ltd. All rights reserved.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 31-40 av 401
Typ av publikation
tidskriftsartikel (371)
forskningsöversikt (14)
konferensbidrag (7)
bokkapitel (7)
annan publikation (2)
Typ av innehåll
refereegranskat (369)
övrigt vetenskapligt/konstnärligt (32)
Författare/redaktör
Bruze, Magnus (401)
Isaksson, Marléne (132)
Svedman, Cecilia (122)
Zimerson, Erik (94)
Gruvberger, Birgitta (64)
Engfeldt, Malin (58)
visa fler...
Goossens, An (56)
Mowitz, Martin (51)
Pontén, Ann (43)
Hindsén, Monica (37)
Dahlin, Jakob (35)
Goncalo, Margarida (31)
Möller, Halvor (30)
Andersen, Klaus E (29)
Antelmi, Annarita (23)
Goh, Chee Leok (21)
Bergendorff, Ola (20)
Menne, T. (19)
Hamnerius, Nils (19)
Svensson, Åke (18)
Björk, Jonas (17)
Persson, Lena (16)
Goossens, A (16)
Elsner, Peter (16)
Andersen, KE (15)
White, Ian R. (14)
Johansen, Jeanne D. (14)
Rustemeyer, Thomas (13)
Stenberg, Berndt (13)
Lejding, Tina (13)
Andersen, Klaus Ejne ... (12)
Bråred Christensson, ... (12)
Belsito, D. (12)
Bickers, D. (12)
Calow, P. (12)
Greim, H. (12)
Sipes, I. G. (12)
Ahlgren, Camilla (11)
Lidén, Carola (11)
Maibach, Howard I. (11)
Sukakul, Thanisorn (11)
Saurat, J. H. (11)
Gimenez Arnau, Ana (11)
Ryberg, Kristina (11)
Diepgen, Thomas (10)
Johansen, JD (10)
Ale, Iris (10)
Sasseville, Denis (10)
Foti, Caterina (10)
Sörensen, Östen (10)
visa färre...
Lärosäte
Lunds universitet (391)
Karolinska Institutet (23)
Göteborgs universitet (21)
Umeå universitet (19)
Malmö universitet (11)
Örebro universitet (9)
visa fler...
Stockholms universitet (5)
Luleå tekniska universitet (3)
Uppsala universitet (1)
Linköpings universitet (1)
visa färre...
Språk
Engelska (395)
Svenska (3)
Odefinierat språk (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (395)
Naturvetenskap (4)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy